Top Rising Cryptocurrencies on Binance: OAX, AKRO, and FIRO Surge
2.17BUSD
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US00973Y1082
CUSIP
00973Y108
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
10.61
Dividend Share
-
Dividend Yield
-
Earnings Share
-3.78
Wall Street Target Price
48.2727
EPS Estimate Current Year
-3.9703
EPS Estimate Next Year
-4.8687
EPS Estimate Current Quarter
-0.9
EPS Estimate Next Quarter
-0.95
Most Recent Quarter
-
Revenue TTM
0
Gross Profit TTM
0
EBITDA
-269,265,984
Profit Margin
0.00%
Return On Assets TTM
-23.17%
Return On Equity TTM
-35.90%
Revenue Per Share TTM
0
Qtly Revenue Growth YOY
0.00%
Diluted Eps TTM
-3.78
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
0
Price Book MRQ
2.9411
Enterprise Value Revenue
0
Enterprise Value EBITDA
-6
474.19
2.68%788.01
1.27%207.96
1.13%525.60
0.00%170.35
-5.37%616.84
-1.11%89.57
-0.99%121.19
-0.44%255.48
-0.31%98.13
-0.03%